| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_NFATC3_0013500 | Exon-Exon | chr16:68225334-68260308 | chr16:68191431-68226405 | 56 nt | 0.4821 |
| hsa_chr16_0275900 | Intergenic-Intergenic | chr16:68225400-68225585 | chr16:68191497-68191682 | 186 nt | 0.5108 |
| hsa_NFATC3_0013600 | Intron-Exon-Intron | chr16:68227637-68248335 | chr16:68193734-68214432 | 141 nt | 0.4184 |
| hsa_NFATC3_0013700 | Intron-Intron | chr16:68229598-68230117 | chr16:68195695-68196214 | 520 nt | 0.4365 |
| hsa_chr16_0276000 | Intergenic-Intergenic | chr16:68230105-68238187 | chr16:68196202-68204284 | 250 nt | 0.3720 |
| hsa_NFATC3_0013800 | Intron-Intron | chr16:68230260-68230663 | chr16:68196357-68196760 | 404 nt | 0.4233 |
| hsa_NFATC3_0013900 | Intron-Intron | chr16:68236623-68245520 | chr16:68202720-68211617 | 250 nt | 0.4200 |
| hsa_NFATC3_0014000 | Intron-Intron | chr16:68236651-68241994 | chr16:68202748-68208091 | 250 nt | 0.2760 |
| hsa_NFATC3_0014100 | Intron-Intron | chr16:68237854-68239364 | chr16:68203951-68205461 | 1511 nt | 0.4083 |
| hsa_NFATC3_0014200 | Intron-Intron | chr16:68240822-68241994 | chr16:68206919-68208091 | 1173 nt | 0.4442 |
A study in human peripheral whole blood samples selected the circNFATC3 for validation but eliminated it from the final age prediction model due to barely detectable expression (Ct >37) in RT-qPCR assays [Wang et al. DOI:10.3389/fgene.2022.1031806].